PHOX2B and neuroblastoma: Based on previous data suggesting PHOX2B overexpression as a possible molecular target for neuroblastoma therapy, we performed two high throughput screenings (HTS) of drugs following a standard drug discovery process, which can be classified into five steps, namely: i.